Schizophrenie als Leitkrankheit der Psychiatrie

• Literatur

• 1 van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature 2010; 468: 203-212
• 2 Vauth R, Cavelti M, Schieting S et al. Recovery bei schizophrenen Störungen: Ergebnis und Prozess im Fokus moderner Behandlung. Schizophrenie Mitteilungen der gfts 2011; 27: 50-57
• 3 Vauth R. Psychologische Mechanismen bei der Entwicklung von Depression und ihre Implikationen für psychotherapeutische Ansatzpunkte bei schizophrenen Störungen. neuro aktuell (im Druck)
• 4 Vauth R. Die umfassende Behandlung schizophrener Störungen als klinische Herausforderung. In: Strauß B, Hohagen F, Caspar F, Hrsg. Lehrbuch Psychotherapie. Teilband 1. Göttingen: Hogrefe; 2007: 611-646
• 5 Kumari V, Peters ER, Fannon D et al. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia. Biol Psychiatry 2009; 66: 594-602
• 6 Linden DE et al. How psychotherapy changes the brain – the contribution of functional neuroimaging [Review]. Molecular psychiatry 2006; 11: 528-538
• 7 Dickerson FB, Lehman AF. Evidence-based psychotherapy for schizophrenia: 2011 update. J Nerv Ment Dis 2011; 199: 520-526
• 8 Garety PA, Bebbington B, Fowler D et al. Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. Psychological Medicine 2007; 37: 1377-1391
• 9 Kuipers E, Garety P, Fowler D et al. Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms. Schizophr Bull 2006; 32 (Suppl. 01) 24-S31
• 10 Rathod S, Phiri P, Kingdon D. Cognitive behavioral therapy for schizophrenia. Psychiatr Clin North Am 2010; 33: 527-536
• 11 Tarrier N. Cognitive behavior therapy for schizophrenia and psychosis: current status and future directions. Clin Schizophr Relat Psychoses 2010; 4: 176-184
• 12 Lysaker PH, Tunze C, Yanos PT et al. Relationships between stereotyped beliefs about mental illness, discrimination experiences, and distressed mood over 1 year among persons with schizophrenia enrolled in rehabilitation. Soc Psychiatry Psychiatr Epidemiol 2011; May 21 [Epub ahead of print]
• 13 Cavelti M, Kvrgic S, Beck EM et al. Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders. Compr Psychiatry 2011; Sep 26 [Epub ahead of print]
• 14 Vauth R, Kleim B, Wirtz M et al. Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry Research 2007; 150: 71-80
• 15 Beck EM, Cavelti M, Kvrgic S et al. Are we addressing the “right stuff” to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Schizophr Res 2012; 132: 42-49
• 16 Corrigan PW, Rafacz J, Rusch N. Examining a progressive model of self-stigma and its impact on people with serious mental illness. Psychiatry Res 2001; 189: 339-343
• 17 Hamann J, Mendel R, Cohen R et al. Psychiatrists’ use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics. Psychiatr Serv 2009; 60: 1107-1112
• 18 Kreyenbuhl J, Nossel IR, Dixon LB. Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature. Schizophrenia Bulletin 2009; 35: 696-703
• 19 Miklowitz DJ, Otto MW, Frank E et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. American Journal of Psychiatry 2007; 164: 1340-1347
• 20 Vauth R. Psychotherapie bei schizophrenen Störungen auf der Grundlage modernen Case Managements. In: Falkai P, Pajonc FG, eds. Langzeittherapie der Schizophrenie. Bremen: Unimed; 2004: 84-97
• 21 Dixon LB, Dickerson F, Bellack AS et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010; 36: 48-70
• 22 Vauth R, Corrigan PW, Clauss M et al. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation. Schizophr Bull 2005; 31: 55-66
• 23 Salize HJ, McCabe R, Bullenkamp J et al. Cost of treatment of schizophrenia in six European countries. Schizophr Res 2009; 111: 70-77
• 24 Puschner B, Vauth R, Jacobi F et al. Evidence basis of psychotherapy for schizophrenia patients in Germany. Nervenarzt 2006; 77: 1301-1302, 1304−1309
• 25 Wobrock T, Pajonk FG, Falkai P. Schizophrenie. Teil 1: Epidemiologie. Ätiopathogenese, Symptomatologie. Fortschr Neurol Psychiat 2004; 72: 98-113
• 26 Meyer C, Rumpf H-J, Hapke U et al. Lebenszeitprävalenz psychischer Störungen in der erwachsenen Allgemeinbevölkerung. Ergebnisse der TACOS-Studie. Nervenarzt 2000; 71: 535-542
• 27 Lotz-Rambaldi W, Hohagen F. Entwicklung der Psychotherapie im Fachgebiet Psychiatrie und Psychotherapie. Erfolgreiche Einbindung. NeuroTransmitter 2009; 2 (Sonderheft): 6-12
• 28 Hohagen F. The profile of a psychiatrist. Nervenarzt 2006; 77: 748-750
• 29 Baxter Jr LR, Schwartz JM, Bergman KS et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-689
• 30 Schwartz JM, Stoessel PW, Baxter Jr LR et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 109-113
• 31 Zurowski B, Kordon A, Weber-Fahr W et al. Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 2012; (in press) DOI:
• 32 Gesundheitsforschungsrat (GFR) des Bundesministeriums für Bildung und Forschung (BMBF). Roadmap für das Gesundheitsforschungsprogramm der Bundesregierung. 2007
• 33 Mathers CD, Loncar D. Updated projections of global mortality and burden of disease, 2002−2030: Data sources, methods and results. Public Library of Science Medicine 2006; 3: e442
• 34 Volk der Erschöpften. DER SPIEGEL 2001; 4: 114-122